Cardlytics Inc

Cardlytics Inc(CDLX)股票分析

$1.950

-0.214 (-10.96%)收盤時

Loading chart…
最高
2.095
開盤
2.080
成交量加權均價
1.99
成交量
46.87K
市值
399.53M
最低
1.930
成交金額
93.35K
企業價值/稅息折舊攤銷前利潤(TTM)
-163.89

Cardlytics, Inc. provides a commerce media platform. Through the Cardlytics platform, its financial media network, marketers can deliver advertising content to customers that allows them to earn rewards, which are funded with a portion of the fees it collects from marketers. It maintains the Cardlytics platform in both the United States (U.S.) and United Kingdom (U.K.). The Cardlytics platform helps marketers find potential new customers that are active in their category but not shopping with them, or to grow their business with existing customers. The Cardlytics platform also provides its marketers a scalable solution for driving customer loyalty and engagement whereby Cardlytics handles everything from contracting with marketers and creating, managing and reporting performance of their campaigns to attributing incentives to each of its partners' customers. The Cardlytics platform helps solve fundamental problems for its financial institutions (FI partners).

AI 分析 of Cardlytics Inc (CDLX)

持有

Cardlytics Inc is not a good buy right now due to its current price of $1.95 being significantly below analyst price targets of $4 and $2. The company has shown a staggering year-to-date change of -82.59% and a one-year change of -86.36%, indicating severe underperformance. Additionally, insider selling has increased by 171.74%, which raises concerns about management's confidence in the company's future. While there are some positive indicators, such as a recent 5-day change of +9.55%, the overall trend and analyst sentiment suggest caution.

分析師評級(6)

-16.41% 下跌空間
買進
5 買進
1 持有
0 賣出
目前: 1.95
最低
1.50
平均
1.63
最高
2.00

BofA

2026-11-07

目標價

$4

落後大盤

Craig-Hallum

2026-11-06

目標價

$4

持有

Lake Street

2026-11-06

目標價

$2

持有

Lake Street

2026-05-08

目標價

$1

持有

Evercore ISI

2026-03-06

目標價

$1

In Line

估值指標

Cardlytics Inc(CDLX)目前預期本益比為 36.50,5 年平均預期本益比為 9.34。

預期本益比

合理
5 年均值 P/E
9.34
目前P/E
36.50
高估
60.24
低估
-41.57

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-94.14
目前EV/EBITDA
-163.89
高估
122.29
低估
-310.57

預期股價營收比

合理
5 年均值 P/S
1.38
目前P/S
0.07
高估
3.25
低估
-0.49

Alphio AI 對 CDLX 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CDLX

$2.43

情境價格

基

基準

基準 · 50%CDLX

$2.03

情境價格

悲

悲觀

悲觀 · 25%CDLX

$2.03

情境價格

持有 CDLX 的大戶

C

CAS Investment Partners, LLC

+ 持有CDLX

-0.02%

3個月報酬率

事件時間軸

2026-10-06 (ET)

10:30:00

Cardlytics Partners with Rove to Expand Rewards Platform

2026-07-29 (ET)

09:00:00

Cardlytics Appoints Chris Cheng as Chief Legal Officer

2026-06-05 (ET)

20:00:00

Cardlytics Trading Halted, News Pending

2026-05-07 (ET)

16:20:00

Cardlytics Q1 Revenue at $34.32M, Below Consensus

16:20:00

Cardlytics Sees Q2 Revenue of $35M-$40M

資訊

CDLX 常見問題 —— 由 Alphio AI 解答

Cardlytics, Inc. provides a commerce media platform. Through the Cardlytics platform, its financial media network, marketers can deliver advertising content to customers that allows them to earn rewards, which are funded with a portion of the fees it collects from marketers. It maintains the Cardlytics platform in both the United States (U.S.) and United Kingdom (U.K.). The Cardlytics platform helps marketers find potential new customers that are active in their category but not shopping with them, or to grow their business with existing customers. The Cardlytics platform also provides its marketers a scalable solution for driving customer loyalty and engagement whereby Cardlytics handles everything from contracting with marketers and creating, managing and reporting performance of their campaigns to attributing incentives to each of its partners' customers. The Cardlytics platform helps solve fundamental problems for its financial institutions (FI partners). It operates in the Technology sector (SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ET industry).

Cardlytics Inc is not a good buy right now due to its current price of $1.95 being significantly below analyst price targets of $4 and $2. The company has shown a staggering year-to-date change of -82.59% and a one-year change of -86.36%, indicating severe underperformance. Additionally, insider selling has increased by 171.74%, which raises concerns about management's confidence in the company's future. While there are some positive indicators, such as a recent 5-day change of +9.55%, the overall trend and analyst sentiment suggest caution.

6 analysts cover CDLX: 5 rate it Buy, 1 Hold and 0 Sell. The average price target is 1.63.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易